Dkk3 Mouse shRNA Plasmid (Locus ID 50781)
CAT#: TL502835
Dkk3 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 7,740.00
货期*
2周
规格
Cited in 1 publication. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | Dkk3 Mouse shRNA Plasmid (Locus ID 50781) |
Locus ID | 50781 |
UniProt ID | Q9QUN9 |
Synonyms | AW061014; C87148; dkk-3; mDkk-3 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | Dkk3 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 50781). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | BC046304, BC050934, NM_015814, NM_001360257, NM_001360260, NM_001360261, NM_015814.1, NM_015814.2, BC005519, NM_015814.3 |
Summary | Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6. DKKs play an important role in vertebrate development, where they locally inhibit Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. In the adult, Dkks are implicated in bone formation and bone disease, cancer and Alzheimer disease (By similarity).[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
,null,
International journal of oncology
,PubMed ID 30569110
[Dkk3]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...